These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. First case of acute cholestatic hepatitis attributed to oseltamivir in a young girl with ah1n1 influenza. Mastroianni A; Greco S; Vangeli V; Ritacca R; Mauro MV; Guadagnino G Ann Ig; 2021; 33(3):205-208. PubMed ID: 33739353 [TBL] [Abstract][Full Text] [Related]
3. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728 [TBL] [Abstract][Full Text] [Related]
4. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796 [TBL] [Abstract][Full Text] [Related]
5. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza. Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654 [TBL] [Abstract][Full Text] [Related]
6. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. Jefferson T; Jones M; Doshi P; Del Mar C BMJ; 2009 Dec; 339():b5106. PubMed ID: 19995812 [TBL] [Abstract][Full Text] [Related]
7. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Sugaya N; Ohashi Y Antimicrob Agents Chemother; 2010 Jun; 54(6):2575-82. PubMed ID: 20368393 [TBL] [Abstract][Full Text] [Related]
8. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547 [TBL] [Abstract][Full Text] [Related]
9. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Heneghan CJ; Onakpoya I; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Spencer EA; Mahtani KR; Nunan D; Howick J; Jefferson T Health Technol Assess; 2016 May; 20(42):1-242. PubMed ID: 27246259 [TBL] [Abstract][Full Text] [Related]
10. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data. Donner B; Niranjan V; Hoffmann G Drug Saf; 2010 Aug; 33(8):631-42. PubMed ID: 20635821 [TBL] [Abstract][Full Text] [Related]
11. Oseltamivir-Induced Mania in a Patient With Influenza A. Ferahkaya E Clin Neuropharmacol; 2021 May-Jun 01; 44(3):106-107. PubMed ID: 33811194 [TBL] [Abstract][Full Text] [Related]
12. Tongue swelling complicating management of a ventilated patient with acute respiratory distress syndrome secondary to novel influenza A (H1N1). Scott A; More R; Freebairn RC Anaesth Intensive Care; 2010 Mar; 38(2):370-2. PubMed ID: 20369775 [TBL] [Abstract][Full Text] [Related]
13. Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction? Simón-Talero M; Buti M; Esteban R J Viral Hepat; 2012 Jan; 19 Suppl 1():14-7. PubMed ID: 22233409 [TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons. Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968 [TBL] [Abstract][Full Text] [Related]
15. Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)v, May 2009 - an internet-based cross-sectional survey. Kitching A; Roche A; Balasegaram S; Heathcock R; Maguire H Euro Surveill; 2009 Jul; 14(30):19287. PubMed ID: 19643062 [TBL] [Abstract][Full Text] [Related]
16. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(32):893-6. PubMed ID: 19696719 [TBL] [Abstract][Full Text] [Related]
17. Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus-infected mice. Takahashi E; Sawabuchi T; Kimoto T; Sakai S; Kido H J Dairy Sci; 2019 Nov; 102(11):9559-9569. PubMed ID: 31495632 [TBL] [Abstract][Full Text] [Related]
18. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1. Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917 [TBL] [Abstract][Full Text] [Related]
19. A/H1N1 flu. Time for case-control studies of NSAIDs and oseltamivir. Herxheimer A; Clarke M; Edwards R; Jefferson T; Loke Y BMJ; 2009 Jul; 339():b3048. PubMed ID: 19638383 [No Abstract] [Full Text] [Related]
20. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. Dharan NJ; Gubareva LV; Meyer JJ; Okomo-Adhiambo M; McClinton RC; Marshall SA; St George K; Epperson S; Brammer L; Klimov AI; Bresee JS; Fry AM; JAMA; 2009 Mar; 301(10):1034-41. PubMed ID: 19255110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]